Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Petros Pharmaceuticals Inc
PTPICurrent price
0.38 USD
-0.015 USD (-3.85%)
Last closed
0.38 USD
Company
www.petrospharma.com
ISIN
US71678J1007
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
3 499 713 USD
Yield for 12 month
-76.27 %
1Y
3Y
5Y
10Y
15Y
PTPI
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 USDP/E ratio
–Dividend Yield
–Current Year
+5 822 388 USD
Last Year
+5 992 054 USD
Current Quarter
+1 421 471 USD
Last Quarter
+1 388 806 USD
Current Year
+908 201 USD
Last Year
+3 702 636 USD
Current Quarter
+374 523 USD
Last Quarter
+1 056 975 USD
Key Figures PTPI
1 year
3 years
5 years
10 years
EBITDA
-10 134 383 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-30.61 %
PEG Ratio
–
Return On Equity TTM
-63.77 %
Wall Street Target Price
1 USD
Revenue TTM
4 120 681 USD
Book Value
0.87 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-28.7 %
Dividend Yield
–
Gross Profit TTM
6 211 698 USD
Earnings per share
-6.25 USD
Diluted Eps TTM
-6.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-171.24 %
Dividend Analytics PTPI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PTPI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
01.12.2022
Dividend Date
–
Stock Valuation PTPI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.1624
Price Sales TTM
0.8493
Enterprise Value EBITDA
-0.1462
Price Book MRQ
0.4337
Financials PTPI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PTPI
For 52 weeks
0.28 USD
2.27 USD
50 Day MA
0.38 USD
Shares Short Prior Month
260 701
200 Day MA
0.89 USD
Short Ratio
2.14
Shares Short
295 849
Short Percent
3.59 %
BeatStart